These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 11910657

  • 1. Comparison of different treatment modalities for postmenopausal patients with osteopenia: hormone replacement therapy, calcitonin and clodronate.
    Tiraş MB, Noyan V, Yildiz A, Biberoğlu K.
    Climacteric; 2000 Jun; 3(2):92-101. PubMed ID: 11910657
    [Abstract] [Full Text] [Related]

  • 2. Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study.
    Kaskani E, Lyritis GP, Kosmidis C, Galanos A, Andypas G, Chorianopoulos K, Giagiosis A, Iliadou K, Karagianis A, Katsimichas K, Koskinas A, Matsouka K.
    Clin Rheumatol; 2005 Jun; 24(3):232-8. PubMed ID: 15647969
    [Abstract] [Full Text] [Related]

  • 3. Effects of continuous combined hormone replacement therapy and clodronate on bone mineral density in osteoporotic postmenopausal women: a 5-year follow-up.
    Tuppurainen M, Härmä K, Komulainen M, Kiviniemi V, Kröger H, Honkanen R, Alhava E, Jurvelin J, Saarikoski S.
    Maturitas; 2010 Aug; 66(4):423-30. PubMed ID: 20547017
    [Abstract] [Full Text] [Related]

  • 4. A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis.
    Hodsman AB, Fraher LJ, Watson PH, Ostbye T, Stitt LW, Adachi JD, Taves DH, Drost D.
    J Clin Endocrinol Metab; 1997 Feb; 82(2):620-8. PubMed ID: 9024265
    [Abstract] [Full Text] [Related]

  • 5. Salmon calcitonin in prevention of osteoporosis in maintenance dialysis patients.
    Wang SX, Li H.
    Chin Med J (Engl); 2008 Jul 20; 121(14):1280-4. PubMed ID: 18713548
    [Abstract] [Full Text] [Related]

  • 6. Effects of alendronate and hormone replacement therapy, alone or in combination, on bone mass in postmenopausal women with osteoporosis: a prospective, randomized study.
    Tiraş MB, Noyan V, Yildiz A, Yildirim M, Daya S.
    Hum Reprod; 2000 Oct 20; 15(10):2087-92. PubMed ID: 11006178
    [Abstract] [Full Text] [Related]

  • 7. Continuous and cyclical clodronate therapies and bone density in postmenopausal bone loss.
    Giannini S, D'Angelo A, Sartori L, Passeri G, Dalle Carbonare L, Crepaldi G.
    Obstet Gynecol; 1996 Sep 20; 88(3):431-6. PubMed ID: 8752254
    [Abstract] [Full Text] [Related]

  • 8. Prevention of bone loss by clodronate in early postmenopausal women with vertebral osteopenia: a dose-finding study.
    Välimäki MJ, Laitinen K, Patronen A, Puolijoki H, Seppänen J, Pylkkänen L, Aranko SM, Sairanen S, Blåfield H, Rekiaro M, Väisänen K, Kormano M, Mäkinen L, Salmi J, Ala-Kaila K, Perttilä J, Vesterinen K, Koivunoro K, Probone Study Group.
    Osteoporos Int; 2002 Dec 20; 13(12):937-47. PubMed ID: 12459936
    [Abstract] [Full Text] [Related]

  • 9. The effect of clodronate and antioestrogens on bone loss associated with oestrogen withdrawal in postmenopausal women with breast cancer.
    Saarto T, Vehmanen L, Elomaa I, Välimäki M, Mäkelä P, Blomqvist C.
    Br J Cancer; 2001 Apr 20; 84(8):1047-51. PubMed ID: 11308252
    [Abstract] [Full Text] [Related]

  • 10. Skeletal effects of cyclic recombinant human growth hormone and salmon calcitonin in osteopenic postmenopausal women.
    Holloway L, Kohlmeier L, Kent K, Marcus R.
    J Clin Endocrinol Metab; 1997 Apr 20; 82(4):1111-7. PubMed ID: 9100582
    [Abstract] [Full Text] [Related]

  • 11. "Twice-a-month" clodronate 200 mg IM: a new dosing regimen and improved therapy adherence in the treatment of postmenopausal osteoporosis.
    Muratore M, Quarta L, Calcagnile F, Quarta E.
    Adv Ther; 2010 May 20; 27(5):314-20. PubMed ID: 20526703
    [Abstract] [Full Text] [Related]

  • 12. Does vitamin D strengthen the increase in femoral neck BMD in osteoporotic women treated with estrogen?
    Tuppurainen MT, Komulainen M, Kröger H, Honkanen R, Jurvelin J, Puntila E, Heikkinen AM, Alhava E, Saarikoski S.
    Osteoporos Int; 1998 May 20; 8(1):32-8. PubMed ID: 9692075
    [Abstract] [Full Text] [Related]

  • 13. A four-year randomized controlled trial of hormone replacement and bisphosphonate, alone or in combination, in women with postmenopausal osteoporosis.
    Wimalawansa SJ.
    Am J Med; 1998 Mar 20; 104(3):219-26. PubMed ID: 9552083
    [Abstract] [Full Text] [Related]

  • 14. The treatment of osteoporosis in patients with rheumatoid arthritis receiving glucocorticoids: a comparison of alendronate and intranasal salmon calcitonin.
    Tascioglu F, Colak O, Armagan O, Alatas O, Oner C.
    Rheumatol Int; 2005 Nov 20; 26(1):21-9. PubMed ID: 15688191
    [Abstract] [Full Text] [Related]

  • 15. A phase 3 trial of the efficacy and safety of oral recombinant calcitonin: the Oral Calcitonin in Postmenopausal Osteoporosis (ORACAL) trial.
    Binkley N, Bolognese M, Sidorowicz-Bialynicka A, Vally T, Trout R, Miller C, Buben CE, Gilligan JP, Krause DS, Oral Calcitonin in Postmenopausal Osteoporosis (ORACAL) Investigators.
    J Bone Miner Res; 2012 Aug 20; 27(8):1821-9. PubMed ID: 22437792
    [Abstract] [Full Text] [Related]

  • 16. Effects of alendronate combined with hormone replacement therapy on osteoporotic postmenopausal Chinese women.
    Tseng LN, Sheu WH, Ho ES, Lan HH, Hu CC, Kao CH.
    Metabolism; 2006 Jun 20; 55(6):741-7. PubMed ID: 16713432
    [Abstract] [Full Text] [Related]

  • 17. Biochemical bone markers and bone mineral density during postmenopausal hormone replacement therapy with and without vitamin D3: a prospective, controlled, randomized study.
    Heikkinen AM, Parviainen M, Niskanen L, Komulainen M, Tuppurainen MT, Kröger H, Saarikoski S.
    J Clin Endocrinol Metab; 1997 Aug 20; 82(8):2476-82. PubMed ID: 9253321
    [Abstract] [Full Text] [Related]

  • 18. Effect of teriparatide [rhPTH(1-34)] on BMD when given to postmenopausal women receiving hormone replacement therapy.
    Ste-Marie LG, Schwartz SL, Hossain A, Desaiah D, Gaich GA.
    J Bone Miner Res; 2006 Feb 20; 21(2):283-91. PubMed ID: 16418784
    [Abstract] [Full Text] [Related]

  • 19. Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study.
    Morabito N, Crisafulli A, Vergara C, Gaudio A, Lasco A, Frisina N, D'Anna R, Corrado F, Pizzoleo MA, Cincotta M, Altavilla D, Ientile R, Squadrito F.
    J Bone Miner Res; 2002 Oct 20; 17(10):1904-12. PubMed ID: 12369794
    [Abstract] [Full Text] [Related]

  • 20. Treatment of post-menopausal osteoporosis with recombinant human growth hormone and salmon calcitonin: a placebo controlled study.
    Gonnelli S, Cepollaro C, Montomoli M, Gennari L, Montagnani A, Palmieri R, Gennari C.
    Clin Endocrinol (Oxf); 1997 Jan 20; 46(1):55-61. PubMed ID: 9059558
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.